AUG 05, 2021 9:35 AM PDT

Brain's Version of THC Reduces Seizures, Increases Side Effects

WRITTEN BY: Annie Lennon

An endocannabinoid similar to tetrahydrocannabinol (THC) that naturally occurs in the brain reduces seizure activity. However, it also fuels a prolonged stroke-like event in the brain. The corresponding study was published in Neuron by researchers from multiple institutions. 

Epileptic seizures are ‘electrical storms’ that usually begin in or near the hippocampus, a part of the brain that plays a significant role in short-term memory, learning, and spatial orientation. These electrical storms later spread throughout the brain, causing symptoms including convulsions and loss of consciousness. 

These seizures also trigger the rapid synthesis of an endocannabinoid called 2-arachidonoylglycerol, or 2-AG. Like THC, it has an affinity for a receptor known as CB1 that is extremely abundant in the brain. While it is known to reduce seizure intensity, it is also known to activate a series of biochemical reactions that result in blood vessel constriction in the brain and thus disorientation and amnesia. 

 

In experiments, the researchers used novel endocannabinoid visualization techniques to track sub-second changes in levels of 2-AG in the hippocampus during normal periods of activity such as running or walking and during brief induced seizures. 

In doing so, they found that several hundred times as much 2-AG was released during a seizure than normal activity and that previously undetected 2-AG activity alone reduced excitatory neurons’ excessive firing during seizures. 

However, they also found that 2-AG is almost immediately converted to arachidonic acid, a building block for a variety of prostaglandin that causes blood vessels to constrict, thus reducing oxygen supply to areas of the brain. 

“A drug that blocks 2-AG’s conversion to arachidonic acid would kill two birds with one stone,” said Ivan Soltesz, senior author of the study. “It would increase 2-AG’s concentration, diminishing seizure severity, and decrease arachidonic acid levels, cutting off the production of blood-vessel-constricting prostaglandins.”

 

Sources: NeuronNeuroscience News

About the Author
University College London
Annie Lennon is a writer whose work also appears in Medical News Today, Psych Central, Psychology Today, and other outlets. When she's not writing, she is COO of Xeurix, an HR startup that assesses jobfit from gamified workplace simulations.
You May Also Like
NOV 30, 2021
Cannabis Sciences
Terpene-Mediated Modulation of Cannabinoid Activity
NOV 30, 2021
Terpene-Mediated Modulation of Cannabinoid Activity
A popular theory – the “entourage effect” – has been gaining traction amongst the cannabis scien ...
JAN 14, 2022
Cannabis Sciences
Myrcene: The Power Terpene
JAN 14, 2022
Myrcene: The Power Terpene
A recent review published in Frontiers in Nutrition highlighted the terpene myrcene’s phytotherapeutic profile and ...
MAR 22, 2022
Drug Discovery & Development
Medical Marijuana May Be Overhyped for Pain, Anxiety, Depression
MAR 22, 2022
Medical Marijuana May Be Overhyped for Pain, Anxiety, Depression
Claims about medical marijuana treating multiple mental health and neurological disorders may be overhyped, according to ...
APR 01, 2022
Cannabis Sciences
Can weed cure Covid?
APR 01, 2022
Can weed cure Covid?
Since legal cannabis has gained momentum throughout the country, so have the reports that it's the cure all for everythi ...
APR 09, 2022
Cannabis Sciences
Advances in Cannabis Sciences at the 2022 Labroots Virtual Event
APR 09, 2022
Advances in Cannabis Sciences at the 2022 Labroots Virtual Event
Labroots hosted its 5th annual Cannabis Science Virtual Event on March 23, 2022. The speaker roster for this free confer ...
APR 21, 2022
Cannabis Sciences
One of the most lucrative skillsets in cannabis
APR 21, 2022
One of the most lucrative skillsets in cannabis
For anyone looking for a well-compensated, in demand job in the cannabis industry, you can't go wrong with becoming an e ...
Loading Comments...